183 related articles for article (PubMed ID: 32650216)
1. A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma.
Lolli C; Altavilla A; Conteduca V; Farolfi A; Casadei C; Schepisi G; Banna GL; De Giorgi U
Crit Rev Oncol Hematol; 2020 Sep; 153():103036. PubMed ID: 32650216
[TBL] [Abstract][Full Text] [Related]
2. Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Martini DJ; Goyal S; Liu Y; Evans ST; Olsen TA; Case K; Magod BL; Brown JT; Yantorni L; Russler GA; Caulfield S; Goldman JM; Nazha B; Harris WB; Kissick HT; Master VA; Kucuk O; Carthon BC; Bilen MA
Oncologist; 2021 Oct; 26(10):e1742-e1750. PubMed ID: 34156726
[TBL] [Abstract][Full Text] [Related]
3. Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma.
de Velasco G; Bex A; Albiges L; Powles T; Rini BI; Motzer RJ; Heng DYC; Escudier B
Eur Urol Oncol; 2019 Sep; 2(5):505-514. PubMed ID: 31377308
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of second-line ICIs combined with TKIs among patients with metastatic renal cell carcinoma: a real-world study.
Zhang H; Chen J; Zhang X; Zhu X; Wang Z; Sun G; Liang J; Chen Y; Shen Y; Liu J; Li X; Wei Q; Liu Z; Zeng H; Shen P
Immunotherapy; 2022 Apr; 14(5):309-320. PubMed ID: 35187953
[No Abstract] [Full Text] [Related]
5. Treatment of elderly patients with metastatic renal cell carcinoma.
Zanardi E; Grassi P; Cavo A; Verzoni E; Maggi C; De Braud F; Boccardo F; Procopio G
Expert Rev Anticancer Ther; 2016; 16(3):323-34. PubMed ID: 26654225
[TBL] [Abstract][Full Text] [Related]
6. [Drug therapy for renal cell carcinoma in the elderly].
Miyake H; Ozono S
Nihon Rinsho; 2017 Apr; 75(4):602-606. PubMed ID: 30549865
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular profile of contemporary treatments of renal cell carcinoma: A single-center prospective study.
Lee K; Lindenfeld L; Echevarria M; Hsu J; Wong FL; Narayan HK; Lau C; Cai L; Pal SK; Armenian SH; Rhee JW
Int J Cardiol; 2023 Jun; 380():40-46. PubMed ID: 36958393
[TBL] [Abstract][Full Text] [Related]
8. First-line ICIs in renal cell carcinoma.
Fiorentino V; Tralongo P; Larocca LM; Pizzimenti C; Martini M; Pierconti F
Hum Vaccin Immunother; 2023 Aug; 19(2):2225386. PubMed ID: 37395601
[TBL] [Abstract][Full Text] [Related]
9. Special populations in metastatic renal cell carcinoma.
Goodstein T; Goldberg I; Acikgoz Y; Hasanov E; Srinivasan R; Singer EA
Curr Opin Oncol; 2024 May; 36(3):186-194. PubMed ID: 38573208
[TBL] [Abstract][Full Text] [Related]
10. Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors.
Esther J; Hale P; Hahn AW; Agarwal N; Maughan BL
Drugs Aging; 2019 May; 36(5):395-401. PubMed ID: 30784023
[TBL] [Abstract][Full Text] [Related]
11. Assessing Outcomes and Prognostic Factors for First-Line Therapy in Elderly Patients With Metastatic Renal Cell Carcinoma: Real-Life Data From a Single United Kingdom Institution.
Uccello M; Alam T; Abbas H; Nair A; Paskins J; Faust G
Clin Genitourin Cancer; 2019 Jun; 17(3):e658-e663. PubMed ID: 31000484
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of combination therapy with tyrosine kinase inhibitors and immune checkpoint inhibitors in metastatic renal cell carcinoma - A retrospective study.
Jammal N; Pan E; Hurwitz M; Abramovitz RB
J Oncol Pharm Pract; 2020 Apr; 26(3):556-563. PubMed ID: 31216241
[TBL] [Abstract][Full Text] [Related]
13. The medical treatment of metastatic renal cell cancer in the elderly: position paper of a SIOG Taskforce.
Bellmunt J; Négrier S; Escudier B; Awada A; Aapro M;
Crit Rev Oncol Hematol; 2009 Jan; 69(1):64-72. PubMed ID: 18774306
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors.
Delcuratolo MD; Tucci M; Turco F; Di Stefano RF; Ungaro A; Audisio M; Samuelly A; Brusa F; Audisio A; Di Maio M; Scagliotti GV; Buttigliero C
Crit Rev Oncol Hematol; 2023 Jan; 181():103881. PubMed ID: 36427772
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
[TBL] [Abstract][Full Text] [Related]
16. Balancing treatment efficacy, toxicity and complication risk in elderly patients with metastatic renal cell carcinoma.
van den Brom RR; van Es SC; Leliveld AM; Gietema JA; Hospers GA; de Jong IJ; de Vries EG; Oosting SF
Cancer Treat Rev; 2016 May; 46():63-72. PubMed ID: 27123882
[TBL] [Abstract][Full Text] [Related]
17. Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors.
Incorvaia L; Madonia G; Corsini LR; Cucinella A; Brando C; Gagliardo C; Santoni M; Fanale D; Inno A; Fazio I; Foti G; Galia M; Badalamenti G; Bazan V; Russo A; Gori S
Crit Rev Oncol Hematol; 2021 Jul; 163():103390. PubMed ID: 34090998
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy in renal cell carcinoma.
Massari F; Di Nunno V; Ciccarese C; Graham J; Porta C; Comito F; Cubelli M; Iacovelli R; Heng DYC
Cancer Treat Rev; 2017 Nov; 60():152-157. PubMed ID: 28992528
[TBL] [Abstract][Full Text] [Related]
19. Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinoma.
Carretero-González A; Salamanca Santamaría J; Castellano D; de Velasco G
Medicine (Baltimore); 2019 Nov; 98(47):e18098. PubMed ID: 31764847
[TBL] [Abstract][Full Text] [Related]
20. Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma.
Gao X; McDermott DF
Cancer J; 2018; 24(4):171-179. PubMed ID: 30119080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
